Neovastat, a naturally occurring multifunctional antiangiogenic drug, in phase III clinical trials.

Neovastat, a naturally occurring multifunctional antiangiogenic drug, in phase III clinical trials.

Item
http://www.wikidata.org/entity/Q34461569
Matrilin-1 is an inhibitor of neovascularization.The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigationBuilding a better TrapAngiogenesis in non-small cell lung cancer. A new target for therapy.Molecular biological design of novel antineoplastic therapies.Perspectives on novel therapies for bronchial carcinoma.Marine-derived angiogenesis inhibitors for cancer therapy.Intrinsic modulation of lymphocyte function by stromal cell network: advance in therapeutic targeting of cancer.Targeting the tumor microenvironment by immunotherapy: part 2.New approaches to selectively target cancer-associated matrix metalloproteinase activity.Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs.Nanoparticles as new tools for inhibition of cancer angiogenesis.Protective role of metalloproteinase inhibitor (AE-941) on ulcerative colitis in rats.Elasmobranch immune cells as a source of novel tumor cell inhibitors: Implications for public health.An MMP-2/MMP-9 inhibitor, 5a, enhances apoptosis induced by ligands of the TNF receptor superfamily in cancer cells.Mitochondria and Angiogenesis.
P2860

Neovastat, a naturally occurring multifunctional antiangiogenic drug, in phase III clinical trials.

Item
http://www.wikidata.org/entity/Q34461569
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Neovastat, a naturally occurri ...... in phase III clinical trials.
@ast
Neovastat, a naturally occurri ...... in phase III clinical trials.
@en
Neovastat, a naturally occurri ...... in phase III clinical trials.
@nl
type
label
Neovastat, a naturally occurri ...... in phase III clinical trials.
@ast
Neovastat, a naturally occurri ...... in phase III clinical trials.
@en
Neovastat, a naturally occurri ...... in phase III clinical trials.
@nl
prefLabel
Neovastat, a naturally occurri ...... in phase III clinical trials.
@ast
Neovastat, a naturally occurri ...... in phase III clinical trials.
@en
Neovastat, a naturally occurri ...... in phase III clinical trials.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Neovastat, a naturally occurri ...... in phase III clinical trials.
@en
P2093
P304
P31
P356
10.1016/S0093-7754(01)90035-1
P433
P478
P577
P698
P921